MyAverix Finance
F · Healthcare
Moberg Pharma AB (publ) (MB8)
Drug Manufacturers - Specialty & Generic
Moberg Pharma AB (publ) (MB8) is listed on F in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-30, reported market cap is $41.97M, P/E ratio is 18.00, net margin is -201.2%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for MB8
Moberg Pharma AB (publ) (MB8) — FAQ
What is Moberg Pharma AB (publ)'s market cap?
Moberg Pharma AB (publ) (MB8) has a reported market cap of $41.97M (data as of 2026-03-30).
What is MB8's P/E ratio?
The price-to-earnings (P/E) ratio for Moberg Pharma AB (publ) (MB8) is 18.00 (data as of 2026-03-30).
Does Moberg Pharma AB (publ) pay a dividend?
Dividend yield is not available in the current snapshot for Moberg Pharma AB (publ) (MB8). Check the MyAverix Finance app for the latest dividend data.
What sector is Moberg Pharma AB (publ) in?
Moberg Pharma AB (publ) (MB8) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is MB8 listed on?
MB8 is listed on F.
What is Moberg Pharma AB (publ)'s net margin?
Moberg Pharma AB (publ) (MB8) reports a net margin of -201.2% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.